Defense, Rates, and Diabetes Tech: Three Very Different Signals With One Message -( $LMT $MODD ) by John F. Heerdink, Jr. July 23, 2026 Read more Stocks Rebound as Earnings Shine While Oil Keeps Everyone Humble – July 21, 2026 -( $AMD $EPRX $INTC $MODD $LPL $NVDA Rise!) by John F. Heerdink, Jr. July 21, 2026 Read more Not Your Grandfather’s Diabetes Kit: Eli Lilly’s Smart Ring Bet and Modular Medical’s Pivot Pump Rewire the Care Stack -( $LLY $MODD ) by John F. Heerdink, Jr. July 21, 2026 Read more The 97% Signal: Why Millions of Diabetes Patients Are Ready to Ditch the Needle — and What One Company Is Doing About It -( $MODD $MDT $PODD $TNDM ) by John F. Heerdink, Jr. July 15, 2026 Read more The Pivot Point: How Modular Medical (NASDAQ: MODD) Is Betting on the 70% of Diabetics That Big Insulin Forgot -( $MODD $PODD $MDT $TNDM ) by John F. Heerdink, Jr. July 14, 2026 Read more Trump Goes Down Under: How Aussie-Style Retirements Could Supercharge Wall Street’s Long Game -( $AMWL $MODD ) by John F. Heerdink, Jr. July 12, 2026 Read more Biotech Sizzles While Beef Soars: Why Investors Are Buying Labs, Not Ribeyes -( $AMWL $EPRX $MODD $XBI ) by John F. Heerdink, Jr. July 11, 2026 Read more From Couch to $50 Copay: Medicare’s Bridge Program and the Long‑Only Case for Obesity as a Chronic‑Care Asset Class -( $LLY MODD $NVO ) by John F. Heerdink, Jr. July 5, 2026 Read more Soft Landing, Hard Numbers: Why a 57,000‑Job Economy May Love $RIVN, $SMWB, and $MODD by John F. Heerdink, Jr. July 2, 2026 Read more Cooler Jobs, Hotter Trades: What A Sub‑100K Payroll Print Can Mean For Your Risk Book-( $LLY $MODD $SMWB $TSM ) by John F. Heerdink, Jr. July 1, 2026 Read more Read more
